Real-world efficacy and safety of peptide receptor radionuclide therapy (PRRT) in gastroenteropancreatic neuroendocrine tumors (GEP-NETs).

Authors

null

Estephany Abou Jokh Casas

Nuclear Medicine Deparment-Hospital Clinico Universitario de Santiago de Compostela, Santiago De Compostela, Spain

Estephany Abou Jokh Casas , Nieves Purificacion Martinez , Urbano Anido Herranz , Jose Manuel Cabezas Agricola , Silvia Varela Ferreiro , Alberto Carral Maseda , Ovidio Fernandez Calvo , Jose Antonio Mato Mato , Zulema Nogareda Seoane , Sofia Rodriguez Martinez de LLano , Maria Quindós Varela , Francisco Baron , Omar Rodriguez Fonseca , Antia Cousillas Castiñeira , Gloria Muñiz Garcia , Jose Maria De Matias Leralta , Pablo Fernández Catalina , Jose Manuel Cameselle Teijeiro , Beatriz Bernardez , Virginia Pubul Nuñez

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session: Neuroendocrine/Carcinoid

Track

Neuroendocrine/Carcinoid

Sub Track

Therapeutics

Citation

J Clin Oncol 39, 2021 (suppl 3; abstr 364)

DOI

10.1200/JCO.2021.39.3_suppl.364

Abstract #

364

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Thorvardur Ragnar Halfdanarson

First Author: Estephany Abou Jokh Casas

First Author: Andreja Frilling

Poster

2017 Gastrointestinal Cancers Symposium

Pancreatic neuroendocrine tumors: A population-based analysis of epidemiology and outcomes.

Pancreatic neuroendocrine tumors: A population-based analysis of epidemiology and outcomes.

First Author: Samer Alsidawi